Evidence map›Paper›PMID 21523452›Full record

ArticleBreast cancer research and treatment2011

Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.

Margaret M Madeleine, Lisa G Johnson, Mari Malkki, Alexa J Resler, Effie W Petersdorf, Barbara McKnight, Kathleen E Malone

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Breast cancer research and treatment, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 6 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 6 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Association between the tumor necrosis factor alpha gene -308G> A polymorphism and the risk of breast cancer: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Oncotarget · 2019
    Article
  16. Cardiac autonomic evaluation in breast cancer patients: role of cytokines and heart rate recovery.Clinical research in cardiology : official journal of the German Cardiac Society · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Margaret M MadeleineProgram in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. mmadelei@fhcrc.org
Lisa G Johnson
Mari Malkki
Alexa J Resler
Effie W Petersdorf
Barbara McKnight
Kathleen E Malone
Fred Hutch Cancer Center · USUniversity of Washington · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZA

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Developing Data-Driven Cancer ResearchersT32CA009168 · NCI · UNIVERSITY OF WASHINGTON · PI STEPHEN M SCHWARTZ, MICHAEL Chiao-An WU · 1985 to 2026
$10.1M
Statistical Methods in Genetic EpidemiologyR01AG014358 · NIA · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HSU, LI · 2002 to 2013
$2.4M
Inflammation Pathways in Breast CancerR01CA116786 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MADELEINE, MARGARET M · 2007 to 2010
$1.9M
BREAST CANCER AND THE BIRTH CONTROL PILL-275923166N01HD023166 · NICHD · FRED HUTCHINSON CANCER RESEARCH CENTER · 1992 to 2003
$1.4M
FACTORS AFFECTING SURVIVAL OF YOUNG CANCER PATIENTSR01CA059736 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MALONE, KATHLEEN E · 1993 to 2002
$1.0M
CALCIUM CHANNEL BLOCKERS IN BREAST CANCER ETIOLOGYR01CA072787 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DALING, JANET R · 1997 to 2001
$704k
GENETIC AND ENVIRONMENTAL DETERMINANTS OF BREAST CANCERR01CA063697 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ZHAO, LUE PING NA · 1994 to 1998
–
POPULATION BASED GENETIC ANALYSIS OF BREAST CANCERR01CA063705 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OSTRANDER, ELAINE A · 1994 to 1998
–
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01CN067009 · CN · FRED HUTCHINSON CANCER RESEARCH CENTER · PI THOMAS, DAVID B · 1996 to 1997
–
BREAST CANCER IN WOMEN UNDER THE AGE OF 45 FIELD CENTERSN01CP095671 · CP · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DALING, JANET R · 1989 to 1993
–
NCI NIH HHS N01 CN067009NCI NIH HHS N01 CP095671NCI NIH HHS N01-CP9567NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA059736NCI NIH HHS R01 CA063697NCI NIH HHS R01 CA063705NCI NIH HHS R01 CA072787NCI NIH HHS R01 CA116786NCI NIH HHS R01-CA-59736NCI NIH HHS R01-CA-63697NCI NIH HHS R01-CA-63705NCI NIH HHS R01 CA72787NCI NIH HHS T32 CA009168NIA NIH HHS R01 AG014358NICHD NIH HHS N01 HD023166NICHD NIH HHS N01 HD 2-3166
6 · The paper itself

Abstract

Proinflammatory cytokines are associated with age-related diseases including arthritis and heart disease. IL6 and TNF also play key roles in estrogen modulation in older women. We explored whether variation in IL6 and TNF genes influenced the risk of breast cancer in samples that differed by age group: <44 years (228 cases and 271 controls), 45-64 years (426 cases and 396 controls), and 65+ years (228 cases and 239 controls). Samples were drawn from population-based case-control studies conducted in Seattle. Age-adjusted odds ratios (ORs) were calculated to evaluate the risk associated with variants in IL6, IL6R, TNF, and TNFRSF1A. There was a significantly increased risk of breast cancer associated with one or more C>T alleles at IL6 rs2069861 among subjects in the oldest age group (OR 1.8, 95% CI 1.1-2.9), but no overall increased risk of breast cancer associated with any IL6 or IL6R variants in the combined data. There were significantly elevated risks of breast cancer among women 45-64 years old associated with a UTR 5' flanking SNP LTA rs2009658 C>G allele (OR 1.5, 95% CI 1.1-1.9) and a nonsynonomous coding SNP TNFRSF1A rs767455 T>C allele (OR 1.3, 95% CI 1.1-1.6); these two variants were also elevated in the combined data (OR 1.3, 95% CI 1.1-1.5 and OR 1.2, 95% CI 1.1-1.4, respectively). This study supports a modest association between a variant in IL6 and breast cancer among older women and TNF-related variants and breast cancer among middle-aged women. Further evaluation of these genes in other studies is warranted.

Indexed as

AdultAgedAllelesBreast NeoplasmsCase-Control StudiesFemaleGenetic Predisposition to DiseaseHumansInterleukin-6Middle AgedOdds RatioPolymorphism, Single NucleotideReceptors, Interleukin-6Receptors, Tumor Necrosis Factor, Type ITumor Necrosis FactorsIL6 protein, humanInterleukin-6Receptors, Interleukin-6Receptors, Tumor Necrosis Factor, Type ITNFRSF1A protein, humanTumor Necrosis Factors

Identifiers

PMID21523452
PMCPMC3164911
OpenAlexW2030678748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.